Jeffrey J. Hessekiel
General Counsel
Cytokinetics Inc (CYTK)Equibles does not estimate personal net worth.
Get an email with a short summary when Cytokinetics Inc publishes a filing, an earnings call transcript or a press release.
Get CYTK alertsAbout Jeffrey J. Hessekiel
Jeffrey J. Hessekiel is recorded as General Counsel at Cytokinetics Inc (CYTK) since November 14, 2025. Earlier roles on record: General Counsel at Exelixis, Inc. (EXEL) until November 7, 2025. Cytokinetics Inc reported in an 8-K filed November 14, 2025 that Jeffrey J. Hessekiel was appointed Executive Vice President, Chief Legal and Administrative Officer, effective November 14, 2025. The proxy statement of Exelixis, Inc. reports total compensation of $8,992,592 for Jeffrey J. Hessekiel in fiscal 2025, including a base salary of $672,374. Disclosed compensation is on record for 9 fiscal years. Cytokinetics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cytokinetics Inc includes Robert Blum (CEO), Robert I. Blum (CEO and Board Member), John T. Henderson, M.D. (Chairman) and 7 others.
“On November 13, 2025, Cytokinetics, Incorporated (the "Company") entered into an employment offer letter (the "Offer Letter") with Jeffrey J. Hessekiel, pursuant to which Mr. Hessekiel has agreed to serve as the Company's Executive Vice President, Chief Legal and Administrative Officer, effective as of November 14, 2025 (the "Start Date").”
Affiliation history
-
Current
2025-11-14–present
-
Cytokinetics Inc (CYTK)
Proxy statement
CurrentStart not stated–present
Last confirmed April 17, 2026
-
Start not stated–2025-11-07
Company network
Leadership on record at Cytokinetics Inc
- Robert Blum CEO
- Robert I. Blum CEO, Board Member
- John T. Henderson, M.D. Chairman
- Sung H. Lee CFO
- Brett Pletcher General Counsel
- Mark A. Schlossberg General Counsel
- Mr. Schlossberg General Counsel
- Mr. Wong Chief Accounting Officer
- Robert Wong Chief Accounting Officer
- Sung Lee Chief Accounting Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Exelixis, Inc. (EXEL) | Former Executive Vice President, General Counsel | $672,374 | $8,992,592 |
| 2025 | Cytokinetics Inc (CYTK) | Executive Vice President, Chief Legal & Administrative Officer | $85,250 | $6,086,217 |
| 2024 | Exelixis, Inc. (EXEL) | Executive Vice President, General Counsel | $685,882 | $3,736,716 |
| 2023 | Exelixis, Inc. (EXEL) | Executive Vice President, General Counsel | $657,175 | $4,562,689 |
| 2022 | Exelixis, Inc. (EXEL) | Executive Vice President, General Counsel | $630,285 | $4,616,110 |
| 2021 | Exelixis, Inc. (EXEL) | Executive Vice President, General Counsel and Secretary | $599,135 | $2,174,751 |
| 2020 | Exelixis, Inc. (EXEL) | Executive Vice President, General Counsel and Secretary | $576,091 | $916,910 |
| 2019 | Exelixis, Inc. (EXEL) | Executive Vice President, General Counsel and Secretary | $553,934 | $838,674 |
| 2018 | Exelixis, Inc. (EXEL) | Executive Vice President and General Counsel | $531,880 | $2,069,716 |
| 2017 | Exelixis, Inc. (EXEL) | Executive Vice President and GeneralCounsel | $507,067 | $3,196,103 |